Your browser doesn't support javascript.
loading
Not enough known about fenofibrate's kidney effects in people with Type 2 diabetes.
Jenkins, Alicia J; O'Connell, Rachel L; Januszewski, Andrzej S; Webster, Angela C; M E Davis, Timothy; Jardine, Meg J; Scott, Russell S; Taskinen, Marja-Riitta; Keech, Anthony C.
Afiliação
  • Jenkins AJ; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
  • O'Connell RL; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.
  • Januszewski AS; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia; Sydney Pharmacy School, The University of Sydney, Camperdown, NSW, Australia.
  • Webster AC; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia; Westmead Applied Research Centre, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; Sydney School of Public Health, University of Sydney, NSW, Australia.
  • M E Davis T; Medical School, University of Western Australia, Fremantle, WA, Australia.
  • Jardine MJ; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia.
  • Scott RS; New Zealand Clinical Research Ltd, Christchurch, New Zealand.
  • Taskinen MR; Cardiovascular Research Group, University of Helsinki, Helsinki, Finland.
  • Keech AC; NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia. Electronic address: anthony.keech@sydney.edu.au.
Diabetes Res Clin Pract ; 210: 111612, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38479447
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenofibrato / Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenofibrato / Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article